发明公开
EP1595871A3 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
审中-公开
代谢型谷氨酸受体拮抗剂及其用于治疗中枢神经系统疾病的用途
- 专利标题： Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
- 专利标题（中）： 代谢型谷氨酸受体拮抗剂及其用于治疗中枢神经系统疾病的用途
-
申请号： EP05017791.4申请日： 2000-06-02
-
公开(公告)号： EP1595871A3公开(公告)日： 2005-11-30
- 发明人: The designation of the inventor has not yet been filed
- 申请人： NPS PHARMACEUTICALS, INC.
- 申请人地址： 383 Colorow Drive Salt Lake City, UT 84108 US
- 专利权人： NPS PHARMACEUTICALS, INC.
- 当前专利权人： NPS PHARMACEUTICALS, INC.
- 当前专利权人地址： 383 Colorow Drive Salt Lake City, UT 84108 US
- 代理机构： Plougmann & Vingtoft A/S
- 优先权： US137272P 19990602
- 主分类号： C07D241/44
- IPC分类号： C07D241/44 ; C07D215/54 ; C07D209/42 ; C07D213/82 ; C07D307/68 ; C07D307/84 ; C07D333/38 ; C07D333/68 ; A61K31/495 ; A61K31/404 ; A61P25/00
摘要：
The present invention provides compounds, and pharmaceutical compositions containing those compounds, that are active at metabotropic glutamate receptors. The compounds are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.
公开/授权文献
信息查询
